1. Home
  2. SLP vs TBLD Comparison

SLP vs TBLD Comparison

Compare SLP & TBLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLP
  • TBLD
  • Stock Information
  • Founded
  • SLP 1996
  • TBLD 2021
  • Country
  • SLP United States
  • TBLD United States
  • Employees
  • SLP N/A
  • TBLD N/A
  • Industry
  • SLP EDP Services
  • TBLD Investment Managers
  • Sector
  • SLP Technology
  • TBLD Finance
  • Exchange
  • SLP Nasdaq
  • TBLD Nasdaq
  • Market Cap
  • SLP 675.9M
  • TBLD 543.1M
  • IPO Year
  • SLP 1997
  • TBLD N/A
  • Fundamental
  • Price
  • SLP $17.16
  • TBLD $18.79
  • Analyst Decision
  • SLP Buy
  • TBLD
  • Analyst Count
  • SLP 7
  • TBLD 0
  • Target Price
  • SLP $40.40
  • TBLD N/A
  • AVG Volume (30 Days)
  • SLP 468.2K
  • TBLD 72.8K
  • Earning Date
  • SLP 07-02-2025
  • TBLD 01-01-0001
  • Dividend Yield
  • SLP 0.35%
  • TBLD 6.65%
  • EPS Growth
  • SLP N/A
  • TBLD N/A
  • EPS
  • SLP 0.36
  • TBLD N/A
  • Revenue
  • SLP $78,564,000.00
  • TBLD N/A
  • Revenue This Year
  • SLP $27.66
  • TBLD N/A
  • Revenue Next Year
  • SLP $6.75
  • TBLD N/A
  • P/E Ratio
  • SLP $48.12
  • TBLD N/A
  • Revenue Growth
  • SLP 21.49
  • TBLD N/A
  • 52 Week Low
  • SLP $17.04
  • TBLD $15.80
  • 52 Week High
  • SLP $49.72
  • TBLD $19.00
  • Technical
  • Relative Strength Index (RSI)
  • SLP 18.67
  • TBLD 60.38
  • Support Level
  • SLP $18.66
  • TBLD $18.64
  • Resistance Level
  • SLP $28.65
  • TBLD $19.00
  • Average True Range (ATR)
  • SLP 1.74
  • TBLD 0.26
  • MACD
  • SLP -1.05
  • TBLD -0.02
  • Stochastic Oscillator
  • SLP 3.78
  • TBLD 58.23

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

About TBLD Thornburg Income Builder Opportunities Trust

Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.

Share on Social Networks: